Back to search

Article

Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human sera

2021-11-24

Abstract excerpt

The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations at specific amino acids that might impede vaccine efficacy. BriLife® (rVSV-ΔG-spike) is a newly developed SARS-CoV-2 vaccine candidate currently in Phase II clinical trials. It...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9915c5c3-d09c-5e16-9345-9e68cc367385
DOI
10.1101/2021.11.22.21266673
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralization of SARS-CoV-2 variants by rVSV-ΔG-spike-elicited human seraDOI 10.1101/2021.11.22.21266673
Select a neighboring publication to make it the new centre.